{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 3197, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019de073-a45e-764e-97a1-b4793295a3f1", "docSlug": "90578b12d3108983c23425e7ddd95d83", "documentTitle": "ATAI | Investor Presentation Deck | 41 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 28, "slideType": "before_after", "function": "present_solution", "notes": "The chart shows a non-inferiority test using the Hamilton Anxiety Rating Scale (Ham-A).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a45e-764e-97a1-b4793295a3f1/28", "deckHref": "/decks/019de073-a45e-764e-97a1-b4793295a3f1", "deckAnchorHref": "/decks/019de073-a45e-764e-97a1-b4793295a3f1#slide-28", "loopMatches": [ { "to": 40, "from": 10, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "5cd92045-52c0-4b53-b15d-4dd6b345ff72", "evidence": "The presentation showcases ATAI Life Sciences' pipeline and progress in developing treatments for mental health disorders.", "position": 1, "objective": "How can we effectively treat mental health disorders?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.7, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 41, "from": 6, "beatId": "54d980bb-d331-41ca-8841-b0eb7beb049c", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The presentation provides a solution by showcasing ATAI Life Sciences' pipeline and progress in developing treatments for mental health disorders.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" }, { "to": 40, "from": 10, "beatId": "4c06d6d1-b3e1-4c1e-bceb-806b8f57a880", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "The presentation provides evidence and proof of the effectiveness of ATAI Life Sciences' treatments through various studies and data.", "position": 4, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-a45e-764e-97a1-b4793295a3f1", "docSlug": "90578b12d3108983c23425e7ddd95d83", "documentTitle": "ATAI | Investor Presentation Deck | 41 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 29, "slideType": "appendix_methodology", "function": "present_framework", "notes": "Slide 29 of the presentation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a45e-764e-97a1-b4793295a3f1/29", "deckHref": "/decks/019de073-a45e-764e-97a1-b4793295a3f1", "deckAnchorHref": "/decks/019de073-a45e-764e-97a1-b4793295a3f1#slide-29", "loopMatches": [ { "to": 40, "from": 10, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "5cd92045-52c0-4b53-b15d-4dd6b345ff72", "evidence": "The presentation showcases ATAI Life Sciences' pipeline and progress in developing treatments for mental health disorders.", "position": 1, "objective": "How can we effectively treat mental health disorders?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.7, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 41, "from": 6, "beatId": "54d980bb-d331-41ca-8841-b0eb7beb049c", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The presentation provides a solution by showcasing ATAI Life Sciences' pipeline and progress in developing treatments for mental health disorders.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" }, { "to": 40, "from": 10, "beatId": "4c06d6d1-b3e1-4c1e-bceb-806b8f57a880", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "The presentation provides evidence and proof of the effectiveness of ATAI Life Sciences' treatments through various studies and data.", "position": 4, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-a45e-764e-97a1-b4793295a3f1", "docSlug": "90578b12d3108983c23425e7ddd95d83", "documentTitle": "ATAI | Investor Presentation Deck | 41 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 30, "slideType": "other", "function": "analyze_data", "notes": "Slide 30. Includes statistical significance markers (*, **, ***).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a45e-764e-97a1-b4793295a3f1/30", "deckHref": "/decks/019de073-a45e-764e-97a1-b4793295a3f1", "deckAnchorHref": "/decks/019de073-a45e-764e-97a1-b4793295a3f1#slide-30", "loopMatches": [ { "to": 40, "from": 10, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "5cd92045-52c0-4b53-b15d-4dd6b345ff72", "evidence": "The presentation showcases ATAI Life Sciences' pipeline and progress in developing treatments for mental health disorders.", "position": 1, "objective": "How can we effectively treat mental health disorders?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.7, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 41, "from": 6, "beatId": "54d980bb-d331-41ca-8841-b0eb7beb049c", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The presentation provides a solution by showcasing ATAI Life Sciences' pipeline and progress in developing treatments for mental health disorders.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" }, { "to": 40, "from": 10, "beatId": "4c06d6d1-b3e1-4c1e-bceb-806b8f57a880", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "The presentation provides evidence and proof of the effectiveness of ATAI Life Sciences' treatments through various studies and data.", "position": 4, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-a45e-764e-97a1-b4793295a3f1", "docSlug": "90578b12d3108983c23425e7ddd95d83", "documentTitle": "ATAI | Investor Presentation Deck | 41 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 31, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide uses topographical brain maps to visualize EEG data changes. Significant channels are marked with black circles.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a45e-764e-97a1-b4793295a3f1/31", "deckHref": "/decks/019de073-a45e-764e-97a1-b4793295a3f1", "deckAnchorHref": "/decks/019de073-a45e-764e-97a1-b4793295a3f1#slide-31", "loopMatches": [ { "to": 40, "from": 10, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "5cd92045-52c0-4b53-b15d-4dd6b345ff72", "evidence": "The presentation showcases ATAI Life Sciences' pipeline and progress in developing treatments for mental health disorders.", "position": 1, "objective": "How can we effectively treat mental health disorders?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.7, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 41, "from": 6, "beatId": "54d980bb-d331-41ca-8841-b0eb7beb049c", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The presentation provides a solution by showcasing ATAI Life Sciences' pipeline and progress in developing treatments for mental health disorders.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" }, { "to": 40, "from": 10, "beatId": "4c06d6d1-b3e1-4c1e-bceb-806b8f57a880", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "The presentation provides evidence and proof of the effectiveness of ATAI Life Sciences' treatments through various studies and data.", "position": 4, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-a45e-764e-97a1-b4793295a3f1", "docSlug": "90578b12d3108983c23425e7ddd95d83", "documentTitle": "ATAI | Investor Presentation Deck | 41 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 32, "slideType": "key_takeaways", "function": "summarize", "notes": "Slide 32 of a presentation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a45e-764e-97a1-b4793295a3f1/32", "deckHref": "/decks/019de073-a45e-764e-97a1-b4793295a3f1", "deckAnchorHref": "/decks/019de073-a45e-764e-97a1-b4793295a3f1#slide-32", "loopMatches": [ { "to": 40, "from": 10, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "5cd92045-52c0-4b53-b15d-4dd6b345ff72", "evidence": "The presentation showcases ATAI Life Sciences' pipeline and progress in developing treatments for mental health disorders.", "position": 1, "objective": "How can we effectively treat mental health disorders?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.7, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 41, "from": 6, "beatId": "54d980bb-d331-41ca-8841-b0eb7beb049c", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The presentation provides a solution by showcasing ATAI Life Sciences' pipeline and progress in developing treatments for mental health disorders.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" }, { "to": 40, "from": 10, "beatId": "4c06d6d1-b3e1-4c1e-bceb-806b8f57a880", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "The presentation provides evidence and proof of the effectiveness of ATAI Life Sciences' treatments through various studies and data.", "position": 4, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-a45e-764e-97a1-b4793295a3f1", "docSlug": "90578b12d3108983c23425e7ddd95d83", "documentTitle": "ATAI | Investor Presentation Deck | 41 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 33, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a45e-764e-97a1-b4793295a3f1/33", "deckHref": "/decks/019de073-a45e-764e-97a1-b4793295a3f1", "deckAnchorHref": "/decks/019de073-a45e-764e-97a1-b4793295a3f1#slide-33", "loopMatches": [ { "to": 40, "from": 10, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "5cd92045-52c0-4b53-b15d-4dd6b345ff72", "evidence": "The presentation showcases ATAI Life Sciences' pipeline and progress in developing treatments for mental health disorders.", "position": 1, "objective": "How can we effectively treat mental health disorders?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.7, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 41, "from": 6, "beatId": "54d980bb-d331-41ca-8841-b0eb7beb049c", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The presentation provides a solution by showcasing ATAI Life Sciences' pipeline and progress in developing treatments for mental health disorders.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" }, { "to": 40, "from": 10, "beatId": "4c06d6d1-b3e1-4c1e-bceb-806b8f57a880", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "The presentation provides evidence and proof of the effectiveness of ATAI Life Sciences' treatments through various studies and data.", "position": 4, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-a45e-764e-97a1-b4793295a3f1", "docSlug": "90578b12d3108983c23425e7ddd95d83", "documentTitle": "ATAI | Investor Presentation Deck | 41 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 34, "slideType": "thesis_headline", "function": "present_solution", "notes": "The slide uses a vertical process flow to show the progression from pre-clinical to clinical phases, mapped against key de-risking milestones.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a45e-764e-97a1-b4793295a3f1/34", "deckHref": "/decks/019de073-a45e-764e-97a1-b4793295a3f1", "deckAnchorHref": "/decks/019de073-a45e-764e-97a1-b4793295a3f1#slide-34", "loopMatches": [ { "to": 40, "from": 10, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "5cd92045-52c0-4b53-b15d-4dd6b345ff72", "evidence": "The presentation showcases ATAI Life Sciences' pipeline and progress in developing treatments for mental health disorders.", "position": 1, "objective": "How can we effectively treat mental health disorders?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.7, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 41, "from": 6, "beatId": "54d980bb-d331-41ca-8841-b0eb7beb049c", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The presentation provides a solution by showcasing ATAI Life Sciences' pipeline and progress in developing treatments for mental health disorders.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" }, { "to": 40, "from": 10, "beatId": "4c06d6d1-b3e1-4c1e-bceb-806b8f57a880", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "The presentation provides evidence and proof of the effectiveness of ATAI Life Sciences' treatments through various studies and data.", "position": 4, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-a45e-764e-97a1-b4793295a3f1", "docSlug": "90578b12d3108983c23425e7ddd95d83", "documentTitle": "ATAI | Investor Presentation Deck | 41 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 35, "slideType": "key_takeaways", "function": "analyze_data", "notes": "The slide uses a grouped bar chart to show T-scores across three cognitive tests (HVLT, Symbol Coding, Category Fluency) for four dosage groups.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a45e-764e-97a1-b4793295a3f1/35", "deckHref": "/decks/019de073-a45e-764e-97a1-b4793295a3f1", "deckAnchorHref": "/decks/019de073-a45e-764e-97a1-b4793295a3f1#slide-35", "loopMatches": [ { "to": 40, "from": 10, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "5cd92045-52c0-4b53-b15d-4dd6b345ff72", "evidence": "The presentation showcases ATAI Life Sciences' pipeline and progress in developing treatments for mental health disorders.", "position": 1, "objective": "How can we effectively treat mental health disorders?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.7, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 41, "from": 6, "beatId": "54d980bb-d331-41ca-8841-b0eb7beb049c", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The presentation provides a solution by showcasing ATAI Life Sciences' pipeline and progress in developing treatments for mental health disorders.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" }, { "to": 40, "from": 10, "beatId": "4c06d6d1-b3e1-4c1e-bceb-806b8f57a880", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "The presentation provides evidence and proof of the effectiveness of ATAI Life Sciences' treatments through various studies and data.", "position": 4, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-a45e-764e-97a1-b4793295a3f1", "docSlug": "90578b12d3108983c23425e7ddd95d83", "documentTitle": "ATAI | Investor Presentation Deck | 41 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 36, "slideType": "appendix_methodology", "function": "present_framework", "notes": "Includes study design diagram and assessment schedule table.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a45e-764e-97a1-b4793295a3f1/36", "deckHref": "/decks/019de073-a45e-764e-97a1-b4793295a3f1", "deckAnchorHref": "/decks/019de073-a45e-764e-97a1-b4793295a3f1#slide-36", "loopMatches": [ { "to": 40, "from": 10, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "5cd92045-52c0-4b53-b15d-4dd6b345ff72", "evidence": "The presentation showcases ATAI Life Sciences' pipeline and progress in developing treatments for mental health disorders.", "position": 1, "objective": "How can we effectively treat mental health disorders?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.7, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 41, "from": 6, "beatId": "54d980bb-d331-41ca-8841-b0eb7beb049c", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The presentation provides a solution by showcasing ATAI Life Sciences' pipeline and progress in developing treatments for mental health disorders.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" }, { "to": 40, "from": 10, "beatId": "4c06d6d1-b3e1-4c1e-bceb-806b8f57a880", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "The presentation provides evidence and proof of the effectiveness of ATAI Life Sciences' treatments through various studies and data.", "position": 4, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-a45e-764e-97a1-b4793295a3f1", "docSlug": "90578b12d3108983c23425e7ddd95d83", "documentTitle": "ATAI | Investor Presentation Deck | 41 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 37, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a45e-764e-97a1-b4793295a3f1/37", "deckHref": "/decks/019de073-a45e-764e-97a1-b4793295a3f1", "deckAnchorHref": "/decks/019de073-a45e-764e-97a1-b4793295a3f1#slide-37", "loopMatches": [ { "to": 40, "from": 10, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "5cd92045-52c0-4b53-b15d-4dd6b345ff72", "evidence": "The presentation showcases ATAI Life Sciences' pipeline and progress in developing treatments for mental health disorders.", "position": 1, "objective": "How can we effectively treat mental health disorders?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.7, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 41, "from": 6, "beatId": "54d980bb-d331-41ca-8841-b0eb7beb049c", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The presentation provides a solution by showcasing ATAI Life Sciences' pipeline and progress in developing treatments for mental health disorders.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" }, { "to": 40, "from": 10, "beatId": "4c06d6d1-b3e1-4c1e-bceb-806b8f57a880", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "The presentation provides evidence and proof of the effectiveness of ATAI Life Sciences' treatments through various studies and data.", "position": 4, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-a45e-764e-97a1-b4793295a3f1", "docSlug": "90578b12d3108983c23425e7ddd95d83", "documentTitle": "ATAI | Investor Presentation Deck | 41 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 38, "slideType": "thesis_headline", "function": "present_solution", "notes": "The slide uses a chemical structure diagram to establish the scientific basis for the product.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a45e-764e-97a1-b4793295a3f1/38", "deckHref": "/decks/019de073-a45e-764e-97a1-b4793295a3f1", "deckAnchorHref": "/decks/019de073-a45e-764e-97a1-b4793295a3f1#slide-38", "loopMatches": [ { "to": 40, "from": 10, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "5cd92045-52c0-4b53-b15d-4dd6b345ff72", "evidence": "The presentation showcases ATAI Life Sciences' pipeline and progress in developing treatments for mental health disorders.", "position": 1, "objective": "How can we effectively treat mental health disorders?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.7, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 41, "from": 6, "beatId": "54d980bb-d331-41ca-8841-b0eb7beb049c", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The presentation provides a solution by showcasing ATAI Life Sciences' pipeline and progress in developing treatments for mental health disorders.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" }, { "to": 40, "from": 10, "beatId": "4c06d6d1-b3e1-4c1e-bceb-806b8f57a880", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "The presentation provides evidence and proof of the effectiveness of ATAI Life Sciences' treatments through various studies and data.", "position": 4, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-a45e-764e-97a1-b4793295a3f1", "docSlug": "90578b12d3108983c23425e7ddd95d83", "documentTitle": "ATAI | Investor Presentation Deck | 41 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 39, "slideType": "appendix_methodology", "function": "present_framework", "notes": "The slide outlines two distinct clinical study parts: a Single Ascending Dose (SAD) study and a crossover comparator study.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a45e-764e-97a1-b4793295a3f1/39", "deckHref": "/decks/019de073-a45e-764e-97a1-b4793295a3f1", "deckAnchorHref": "/decks/019de073-a45e-764e-97a1-b4793295a3f1#slide-39", "loopMatches": [ { "to": 40, "from": 10, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "5cd92045-52c0-4b53-b15d-4dd6b345ff72", "evidence": "The presentation showcases ATAI Life Sciences' pipeline and progress in developing treatments for mental health disorders.", "position": 1, "objective": "How can we effectively treat mental health disorders?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.7, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 41, "from": 6, "beatId": "54d980bb-d331-41ca-8841-b0eb7beb049c", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The presentation provides a solution by showcasing ATAI Life Sciences' pipeline and progress in developing treatments for mental health disorders.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" }, { "to": 40, "from": 10, "beatId": "4c06d6d1-b3e1-4c1e-bceb-806b8f57a880", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "The presentation provides evidence and proof of the effectiveness of ATAI Life Sciences' treatments through various studies and data.", "position": 4, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-a45e-764e-97a1-b4793295a3f1", "docSlug": "90578b12d3108983c23425e7ddd95d83", "documentTitle": "ATAI | Investor Presentation Deck | 41 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 40, "slideType": "key_takeaways", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a45e-764e-97a1-b4793295a3f1/40", "deckHref": "/decks/019de073-a45e-764e-97a1-b4793295a3f1", "deckAnchorHref": "/decks/019de073-a45e-764e-97a1-b4793295a3f1#slide-40", "loopMatches": [ { "to": 40, "from": 10, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "5cd92045-52c0-4b53-b15d-4dd6b345ff72", "evidence": "The presentation showcases ATAI Life Sciences' pipeline and progress in developing treatments for mental health disorders.", "position": 1, "objective": "How can we effectively treat mental health disorders?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.7, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 41, "from": 6, "beatId": "54d980bb-d331-41ca-8841-b0eb7beb049c", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The presentation provides a solution by showcasing ATAI Life Sciences' pipeline and progress in developing treatments for mental health disorders.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" }, { "to": 40, "from": 10, "beatId": "4c06d6d1-b3e1-4c1e-bceb-806b8f57a880", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "The presentation provides evidence and proof of the effectiveness of ATAI Life Sciences' treatments through various studies and data.", "position": 4, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-a45e-764e-97a1-b4793295a3f1", "docSlug": "90578b12d3108983c23425e7ddd95d83", "documentTitle": "ATAI | Investor Presentation Deck | 41 slides", "authorId": "atai", "authorName": "atai Life Sciences", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 41, "slideType": "closing_ask", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a45e-764e-97a1-b4793295a3f1/41", "deckHref": "/decks/019de073-a45e-764e-97a1-b4793295a3f1", "deckAnchorHref": "/decks/019de073-a45e-764e-97a1-b4793295a3f1#slide-41", "loopMatches": [], "arcBeatMatches": [ { "to": 41, "from": 6, "beatId": "54d980bb-d331-41ca-8841-b0eb7beb049c", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The presentation provides a solution by showcasing ATAI Life Sciences' pipeline and progress in developing treatments for mental health disorders.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-a4f9-77e5-8cbf-a98a0ec20f41", "docSlug": "527bf315fca9a14279ec523dc4665564", "documentTitle": "Athira Pharma | Results Presentation Deck | 11 slides", "authorId": "athira-pharma", "authorName": "Athira Pharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": "Includes company logo, date, and corporate tagline.", "imagePath": "https://imgproxy.kitesheet.com/YkHTpRh3M-crvAAThhbPxvIf4pMnWh3aWMC4ZCUAyOc/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy81MjdiZjMxNWZjYTlhMTQyNzllYzUyM2RjNDY2NTU2NC9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a4f9-77e5-8cbf-a98a0ec20f41/1", "deckHref": "/decks/019de073-a4f9-77e5-8cbf-a98a0ec20f41", "deckAnchorHref": "/decks/019de073-a4f9-77e5-8cbf-a98a0ec20f41#slide-1", "loopMatches": [ { "to": 3, "from": 1, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "fdab6818-6721-40ae-8f52-56294433f949", "evidence": "Emphasis on current limitations and need for new therapies", "position": 0, "objective": "What is the cost of not developing new therapies for Alzheimer's disease?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 1, "from": 1, "beatId": "ee1f58cb-deae-4bb0-88ac-740963afbb70", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem", "beatSlug": "problem-agitate-solution-problem-identify-pain", "evidence": "Alzheimer's disease affects millions, current therapies are limited", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": "https://imgproxy.kitesheet.com/v8GQeWXhFP6nN1A8nfvVl1zXboZ9JvCY-hslMaEc5xQ/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy81MjdiZjMxNWZjYTlhMTQyNzllYzUyM2RjNDY2NTU2NC9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/sqjka-O6Ea8gQCSGUiWWH2zhFlztI3HCn8yT7fEsvO8/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy81MjdiZjMxNWZjYTlhMTQyNzllYzUyM2RjNDY2NTU2NC9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/FpIYl0SpP7Ak3rzNGAqPaaet_LsxUHGFSuzF7Bk_yAc/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy81MjdiZjMxNWZjYTlhMTQyNzllYzUyM2RjNDY2NTU2NC9wMDAxLnBuZw" }, { "docId": "019de073-a4f9-77e5-8cbf-a98a0ec20f41", "docSlug": "527bf315fca9a14279ec523dc4665564", "documentTitle": "Athira Pharma | Results Presentation Deck | 11 slides", "authorId": "athira-pharma", "authorName": "Athira Pharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a4f9-77e5-8cbf-a98a0ec20f41/2", "deckHref": "/decks/019de073-a4f9-77e5-8cbf-a98a0ec20f41", "deckAnchorHref": "/decks/019de073-a4f9-77e5-8cbf-a98a0ec20f41#slide-2", "loopMatches": [ { "to": 3, "from": 1, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "fdab6818-6721-40ae-8f52-56294433f949", "evidence": "Emphasis on current limitations and need for new therapies", "position": 0, "objective": "What is the cost of not developing new therapies for Alzheimer's disease?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 3, "from": 2, "beatId": "fa2c27bc-ebb6-4ff4-b2b4-2a4c0a80b0f4", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Agitate", "beatSlug": "problem-agitate-solution-agitate-make-it-worse", "evidence": "Current treatments have limitations, new therapies are needed", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-a4f9-77e5-8cbf-a98a0ec20f41", "docSlug": "527bf315fca9a14279ec523dc4665564", "documentTitle": "Athira Pharma | Results Presentation Deck | 11 slides", "authorId": "athira-pharma", "authorName": "Athira Pharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "key_takeaways", "function": "summarize", "notes": "The slide uses a bulleted list to summarize clinical trial milestones and data-driven decision-making.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a4f9-77e5-8cbf-a98a0ec20f41/3", "deckHref": "/decks/019de073-a4f9-77e5-8cbf-a98a0ec20f41", "deckAnchorHref": "/decks/019de073-a4f9-77e5-8cbf-a98a0ec20f41#slide-3", "loopMatches": [ { "to": 3, "from": 1, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "fdab6818-6721-40ae-8f52-56294433f949", "evidence": "Emphasis on current limitations and need for new therapies", "position": 0, "objective": "What is the cost of not developing new therapies for Alzheimer's disease?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 3, "from": 2, "beatId": "fa2c27bc-ebb6-4ff4-b2b4-2a4c0a80b0f4", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Agitate", "beatSlug": "problem-agitate-solution-agitate-make-it-worse", "evidence": "Current treatments have limitations, new therapies are needed", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-a4f9-77e5-8cbf-a98a0ec20f41", "docSlug": "527bf315fca9a14279ec523dc4665564", "documentTitle": "Athira Pharma | Results Presentation Deck | 11 slides", "authorId": "athira-pharma", "authorName": "Athira Pharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "team_bio", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a4f9-77e5-8cbf-a98a0ec20f41/4", "deckHref": "/decks/019de073-a4f9-77e5-8cbf-a98a0ec20f41", "deckAnchorHref": "/decks/019de073-a4f9-77e5-8cbf-a98a0ec20f41#slide-4", "loopMatches": [ { "to": 11, "from": 4, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "8b9b785b-4f0f-46be-8af5-f2f0d1f429d0", "evidence": "Clear presentation of study results and next steps", "position": 1, "objective": "What are the key takeaways from the Phase 2/3 LIFT-AD study?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.7, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 11, "from": 4, "beatId": "ec20a1da-004a-4f5b-ac24-cdc67eafb0cd", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Fosgonimeton shows promise as a new potential therapy for Alzheimer's disease", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-a4f9-77e5-8cbf-a98a0ec20f41", "docSlug": "527bf315fca9a14279ec523dc4665564", "documentTitle": "Athira Pharma | Results Presentation Deck | 11 slides", "authorId": "athira-pharma", "authorName": "Athira Pharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "key_takeaways", "function": "analyze_data", "notes": "The chart shows a significant p-value of 0.018 for NfL reduction. The study design is noted as randomized, double-blind, placebo-controlled, and parallel-group.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a4f9-77e5-8cbf-a98a0ec20f41/5", "deckHref": "/decks/019de073-a4f9-77e5-8cbf-a98a0ec20f41", "deckAnchorHref": "/decks/019de073-a4f9-77e5-8cbf-a98a0ec20f41#slide-5", "loopMatches": [ { "to": 11, "from": 4, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "8b9b785b-4f0f-46be-8af5-f2f0d1f429d0", "evidence": "Clear presentation of study results and next steps", "position": 1, "objective": "What are the key takeaways from the Phase 2/3 LIFT-AD study?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.7, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 11, "from": 4, "beatId": "ec20a1da-004a-4f5b-ac24-cdc67eafb0cd", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Fosgonimeton shows promise as a new potential therapy for Alzheimer's disease", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-a4f9-77e5-8cbf-a98a0ec20f41", "docSlug": "527bf315fca9a14279ec523dc4665564", "documentTitle": "Athira Pharma | Results Presentation Deck | 11 slides", "authorId": "athira-pharma", "authorName": "Athira Pharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "other", "function": "present_framework", "notes": "The slide uses a process-flow style table to outline the clinical trial structure.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a4f9-77e5-8cbf-a98a0ec20f41/6", "deckHref": "/decks/019de073-a4f9-77e5-8cbf-a98a0ec20f41", "deckAnchorHref": "/decks/019de073-a4f9-77e5-8cbf-a98a0ec20f41#slide-6", "loopMatches": [ { "to": 11, "from": 4, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "8b9b785b-4f0f-46be-8af5-f2f0d1f429d0", "evidence": "Clear presentation of study results and next steps", "position": 1, "objective": "What are the key takeaways from the Phase 2/3 LIFT-AD study?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.7, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 11, "from": 4, "beatId": "ec20a1da-004a-4f5b-ac24-cdc67eafb0cd", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Fosgonimeton shows promise as a new potential therapy for Alzheimer's disease", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-a4f9-77e5-8cbf-a98a0ec20f41", "docSlug": "527bf315fca9a14279ec523dc4665564", "documentTitle": "Athira Pharma | Results Presentation Deck | 11 slides", "authorId": "athira-pharma", "authorName": "Athira Pharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "timeline", "function": "plan_implementation", "notes": "The slide uses a list format to show progress/process steps.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a4f9-77e5-8cbf-a98a0ec20f41/7", "deckHref": "/decks/019de073-a4f9-77e5-8cbf-a98a0ec20f41", "deckAnchorHref": "/decks/019de073-a4f9-77e5-8cbf-a98a0ec20f41#slide-7", "loopMatches": [ { "to": 11, "from": 4, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "8b9b785b-4f0f-46be-8af5-f2f0d1f429d0", "evidence": "Clear presentation of study results and next steps", "position": 1, "objective": "What are the key takeaways from the Phase 2/3 LIFT-AD study?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.7, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 11, "from": 4, "beatId": "ec20a1da-004a-4f5b-ac24-cdc67eafb0cd", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Fosgonimeton shows promise as a new potential therapy for Alzheimer's disease", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-a4f9-77e5-8cbf-a98a0ec20f41", "docSlug": "527bf315fca9a14279ec523dc4665564", "documentTitle": "Athira Pharma | Results Presentation Deck | 11 slides", "authorId": "athira-pharma", "authorName": "Athira Pharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "appendix_methodology", "function": "present_framework", "notes": "The framework is a clinical trial decision matrix based on ADAS-Cog11 and ADCS-ADL23 scores.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a4f9-77e5-8cbf-a98a0ec20f41/8", "deckHref": "/decks/019de073-a4f9-77e5-8cbf-a98a0ec20f41", "deckAnchorHref": "/decks/019de073-a4f9-77e5-8cbf-a98a0ec20f41#slide-8", "loopMatches": [ { "to": 11, "from": 4, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "8b9b785b-4f0f-46be-8af5-f2f0d1f429d0", "evidence": "Clear presentation of study results and next steps", "position": 1, "objective": "What are the key takeaways from the Phase 2/3 LIFT-AD study?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.7, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 11, "from": 4, "beatId": "ec20a1da-004a-4f5b-ac24-cdc67eafb0cd", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Fosgonimeton shows promise as a new potential therapy for Alzheimer's disease", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-a4f9-77e5-8cbf-a98a0ec20f41", "docSlug": "527bf315fca9a14279ec523dc4665564", "documentTitle": "Athira Pharma | Results Presentation Deck | 11 slides", "authorId": "athira-pharma", "authorName": "Athira Pharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a4f9-77e5-8cbf-a98a0ec20f41/9", "deckHref": "/decks/019de073-a4f9-77e5-8cbf-a98a0ec20f41", "deckAnchorHref": "/decks/019de073-a4f9-77e5-8cbf-a98a0ec20f41#slide-9", "loopMatches": [ { "to": 11, "from": 4, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "8b9b785b-4f0f-46be-8af5-f2f0d1f429d0", "evidence": "Clear presentation of study results and next steps", "position": 1, "objective": "What are the key takeaways from the Phase 2/3 LIFT-AD study?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.7, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 11, "from": 4, "beatId": "ec20a1da-004a-4f5b-ac24-cdc67eafb0cd", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Fosgonimeton shows promise as a new potential therapy for Alzheimer's disease", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-a4f9-77e5-8cbf-a98a0ec20f41", "docSlug": "527bf315fca9a14279ec523dc4665564", "documentTitle": "Athira Pharma | Results Presentation Deck | 11 slides", "authorId": "athira-pharma", "authorName": "Athira Pharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "roadmap", "function": "state_next_steps", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a4f9-77e5-8cbf-a98a0ec20f41/10", "deckHref": "/decks/019de073-a4f9-77e5-8cbf-a98a0ec20f41", "deckAnchorHref": "/decks/019de073-a4f9-77e5-8cbf-a98a0ec20f41#slide-10", "loopMatches": [ { "to": 11, "from": 4, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "8b9b785b-4f0f-46be-8af5-f2f0d1f429d0", "evidence": "Clear presentation of study results and next steps", "position": 1, "objective": "What are the key takeaways from the Phase 2/3 LIFT-AD study?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.7, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 11, "from": 4, "beatId": "ec20a1da-004a-4f5b-ac24-cdc67eafb0cd", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Fosgonimeton shows promise as a new potential therapy for Alzheimer's disease", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-a4f9-77e5-8cbf-a98a0ec20f41", "docSlug": "527bf315fca9a14279ec523dc4665564", "documentTitle": "Athira Pharma | Results Presentation Deck | 11 slides", "authorId": "athira-pharma", "authorName": "Athira Pharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "problem_statement", "function": "size_opportunity", "notes": "The slide uses a grid of metrics to establish the market size and the problem (lack of new treatments).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a4f9-77e5-8cbf-a98a0ec20f41/11", "deckHref": "/decks/019de073-a4f9-77e5-8cbf-a98a0ec20f41", "deckAnchorHref": "/decks/019de073-a4f9-77e5-8cbf-a98a0ec20f41#slide-11", "loopMatches": [ { "to": 11, "from": 4, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "8b9b785b-4f0f-46be-8af5-f2f0d1f429d0", "evidence": "Clear presentation of study results and next steps", "position": 1, "objective": "What are the key takeaways from the Phase 2/3 LIFT-AD study?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.7, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 11, "from": 4, "beatId": "ec20a1da-004a-4f5b-ac24-cdc67eafb0cd", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Fosgonimeton shows promise as a new potential therapy for Alzheimer's disease", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-a59c-77cf-8e75-229e6c5c9530", "docSlug": "74412512a1adb89488775a4a2b6a1b7b", "documentTitle": "Avenue Therapeutics | IPO Presentation Deck | 30 slides", "authorId": "avenue-therapeutics", "authorName": "Avenue Therapeutics", "documentKindSlug": "regulatory-filing", "documentKindLabel": "Regulatory filing", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/-TA6c74k5aEmIL5qW5eHlFYytFPLaiJF3IcXDRi0Fi4/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy83NDQxMjUxMmExYWRiODk0ODg3NzVhNGEyYjZhMWI3Yi9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a59c-77cf-8e75-229e6c5c9530/1", "deckHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530", "deckAnchorHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/KLDZQXLDXyFGVCLCvj305hNj8kI5XL_17le3MPvtezU/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy83NDQxMjUxMmExYWRiODk0ODg3NzVhNGEyYjZhMWI3Yi9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/OPu-8rgwOp1fE1bFgRcqX6BNwqZs0deXQDDt0d9GSfg/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy83NDQxMjUxMmExYWRiODk0ODg3NzVhNGEyYjZhMWI3Yi9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/j4GbOXHSk8jb2z1oBr829bUfhRSoSfKDWm_3J2OD5hs/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy83NDQxMjUxMmExYWRiODk0ODg3NzVhNGEyYjZhMWI3Yi9wMDAxLnBuZw" }, { "docId": "019de073-a59c-77cf-8e75-229e6c5c9530", "docSlug": "74412512a1adb89488775a4a2b6a1b7b", "documentTitle": "Avenue Therapeutics | IPO Presentation Deck | 30 slides", "authorId": "avenue-therapeutics", "authorName": "Avenue Therapeutics", "documentKindSlug": "regulatory-filing", "documentKindLabel": "Regulatory filing", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 2, "slideType": "disclaimer", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a59c-77cf-8e75-229e6c5c9530/2", "deckHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530", "deckAnchorHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-a59c-77cf-8e75-229e6c5c9530", "docSlug": "74412512a1adb89488775a4a2b6a1b7b", "documentTitle": "Avenue Therapeutics | IPO Presentation Deck | 30 slides", "authorId": "avenue-therapeutics", "authorName": "Avenue Therapeutics", "documentKindSlug": "regulatory-filing", "documentKindLabel": "Regulatory filing", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 3, "slideType": "appendix_data", "function": "establish_context", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a59c-77cf-8e75-229e6c5c9530/3", "deckHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530", "deckAnchorHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530#slide-3", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-a59c-77cf-8e75-229e6c5c9530", "docSlug": "74412512a1adb89488775a4a2b6a1b7b", "documentTitle": "Avenue Therapeutics | IPO Presentation Deck | 30 slides", "authorId": "avenue-therapeutics", "authorName": "Avenue Therapeutics", "documentKindSlug": "regulatory-filing", "documentKindLabel": "Regulatory filing", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 4, "slideType": "executive_summary", "function": "summarize", "notes": "The slide features a high-quality illustration of neurons, emphasizing the CNS focus of the company.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a59c-77cf-8e75-229e6c5c9530/4", "deckHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530", "deckAnchorHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530#slide-4", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-a59c-77cf-8e75-229e6c5c9530", "docSlug": "74412512a1adb89488775a4a2b6a1b7b", "documentTitle": "Avenue Therapeutics | IPO Presentation Deck | 30 slides", "authorId": "avenue-therapeutics", "authorName": "Avenue Therapeutics", "documentKindSlug": "regulatory-filing", "documentKindLabel": "Regulatory filing", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 5, "slideType": "comparison_table", "function": "compare_peers", "notes": "The slide uses a simple additive equation visual to represent the growth of the company's CNS portfolio.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a59c-77cf-8e75-229e6c5c9530/5", "deckHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530", "deckAnchorHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530#slide-5", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-a59c-77cf-8e75-229e6c5c9530", "docSlug": "74412512a1adb89488775a4a2b6a1b7b", "documentTitle": "Avenue Therapeutics | IPO Presentation Deck | 30 slides", "authorId": "avenue-therapeutics", "authorName": "Avenue Therapeutics", "documentKindSlug": "regulatory-filing", "documentKindLabel": "Regulatory filing", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 6, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a Gantt-style visualization to track drug development progress.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a59c-77cf-8e75-229e6c5c9530/6", "deckHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530", "deckAnchorHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530#slide-6", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-a59c-77cf-8e75-229e6c5c9530", "docSlug": "74412512a1adb89488775a4a2b6a1b7b", "documentTitle": "Avenue Therapeutics | IPO Presentation Deck | 30 slides", "authorId": "avenue-therapeutics", "authorName": "Avenue Therapeutics", "documentKindSlug": "regulatory-filing", "documentKindLabel": "Regulatory filing", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 7, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a numbered process flow to indicate strategic priorities.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a59c-77cf-8e75-229e6c5c9530/7", "deckHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530", "deckAnchorHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530#slide-7", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-a59c-77cf-8e75-229e6c5c9530", "docSlug": "74412512a1adb89488775a4a2b6a1b7b", "documentTitle": "Avenue Therapeutics | IPO Presentation Deck | 30 slides", "authorId": "avenue-therapeutics", "authorName": "Avenue Therapeutics", "documentKindSlug": "regulatory-filing", "documentKindLabel": "Regulatory filing", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 8, "slideType": "thesis_headline", "function": "establish_context", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a59c-77cf-8e75-229e6c5c9530/8", "deckHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530", "deckAnchorHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530#slide-8", "loopMatches": [], "arcBeatMatches": [ { "to": 10, "from": 8, "beatId": "618a2f9e-df9a-49da-a0ea-04fb4bfa7948", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Slides 8-10 present BAER-101 as a solution, describing its mechanism of action and therapeutic potential.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-a59c-77cf-8e75-229e6c5c9530", "docSlug": "74412512a1adb89488775a4a2b6a1b7b", "documentTitle": "Avenue Therapeutics | IPO Presentation Deck | 30 slides", "authorId": "avenue-therapeutics", "authorName": "Avenue Therapeutics", "documentKindSlug": "regulatory-filing", "documentKindLabel": "Regulatory filing", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 9, "slideType": "executive_summary", "function": "establish_context", "notes": "Includes a scientific diagram of the GABAa receptor complex.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a59c-77cf-8e75-229e6c5c9530/9", "deckHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530", "deckAnchorHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530#slide-9", "loopMatches": [], "arcBeatMatches": [ { "to": 10, "from": 8, "beatId": "618a2f9e-df9a-49da-a0ea-04fb4bfa7948", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Slides 8-10 present BAER-101 as a solution, describing its mechanism of action and therapeutic potential.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-a59c-77cf-8e75-229e6c5c9530", "docSlug": "74412512a1adb89488775a4a2b6a1b7b", "documentTitle": "Avenue Therapeutics | IPO Presentation Deck | 30 slides", "authorId": "avenue-therapeutics", "authorName": "Avenue Therapeutics", "documentKindSlug": "regulatory-filing", "documentKindLabel": "Regulatory filing", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 10, "slideType": "comparison_table", "function": "compare_peers", "notes": "The table uses checkmarks to indicate the strength of effect for different GABA-A subtypes (alpha 1, 2, 3, 5).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a59c-77cf-8e75-229e6c5c9530/10", "deckHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530", "deckAnchorHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530#slide-10", "loopMatches": [], "arcBeatMatches": [ { "to": 10, "from": 8, "beatId": "618a2f9e-df9a-49da-a0ea-04fb4bfa7948", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Slides 8-10 present BAER-101 as a solution, describing its mechanism of action and therapeutic potential.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-a59c-77cf-8e75-229e6c5c9530", "docSlug": "74412512a1adb89488775a4a2b6a1b7b", "documentTitle": "Avenue Therapeutics | IPO Presentation Deck | 30 slides", "authorId": "avenue-therapeutics", "authorName": "Avenue Therapeutics", "documentKindSlug": "regulatory-filing", "documentKindLabel": "Regulatory filing", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 11, "slideType": "problem_statement", "function": "diagnose_problem", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a59c-77cf-8e75-229e6c5c9530/11", "deckHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530", "deckAnchorHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530#slide-11", "loopMatches": [ { "to": 14, "from": 11, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "e6485657-8caf-4343-bf92-1e9c148fd1b1", "evidence": "The loop is opened on slide 11, highlighting the limitations of current treatments, and closed on slide 14, presenting BAER-101 as a solution.", "position": 0, "objective": "What are the consequences of not addressing the unmet needs in epilepsy and acute anxiety treatment?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 12, "from": 11, "beatId": "5260138e-00d3-4228-841b-29589c8a9035", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "Slides 11 and 12 present the problem statement, highlighting the unmet needs in epilepsy and acute anxiety treatment.", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-a59c-77cf-8e75-229e6c5c9530", "docSlug": "74412512a1adb89488775a4a2b6a1b7b", "documentTitle": "Avenue Therapeutics | IPO Presentation Deck | 30 slides", "authorId": "avenue-therapeutics", "authorName": "Avenue Therapeutics", "documentKindSlug": "regulatory-filing", "documentKindLabel": "Regulatory filing", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 12, "slideType": "problem_statement", "function": "diagnose_problem", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a59c-77cf-8e75-229e6c5c9530/12", "deckHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530", "deckAnchorHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530#slide-12", "loopMatches": [ { "to": 14, "from": 11, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "e6485657-8caf-4343-bf92-1e9c148fd1b1", "evidence": "The loop is opened on slide 11, highlighting the limitations of current treatments, and closed on slide 14, presenting BAER-101 as a solution.", "position": 0, "objective": "What are the consequences of not addressing the unmet needs in epilepsy and acute anxiety treatment?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 12, "from": 11, "beatId": "5260138e-00d3-4228-841b-29589c8a9035", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "Slides 11 and 12 present the problem statement, highlighting the unmet needs in epilepsy and acute anxiety treatment.", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-a59c-77cf-8e75-229e6c5c9530", "docSlug": "74412512a1adb89488775a4a2b6a1b7b", "documentTitle": "Avenue Therapeutics | IPO Presentation Deck | 30 slides", "authorId": "avenue-therapeutics", "authorName": "Avenue Therapeutics", "documentKindSlug": "regulatory-filing", "documentKindLabel": "Regulatory filing", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 13, "slideType": "market_sizing", "function": "size_opportunity", "notes": "Uses a Venn-like containment diagram to show sub-segments of a larger market.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a59c-77cf-8e75-229e6c5c9530/13", "deckHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530", "deckAnchorHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530#slide-13", "loopMatches": [ { "to": 14, "from": 11, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "e6485657-8caf-4343-bf92-1e9c148fd1b1", "evidence": "The loop is opened on slide 11, highlighting the limitations of current treatments, and closed on slide 14, presenting BAER-101 as a solution.", "position": 0, "objective": "What are the consequences of not addressing the unmet needs in epilepsy and acute anxiety treatment?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 14, "from": 13, "beatId": "3c1a1939-0c77-485a-99c7-2e27cc46a9e7", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Size", "beatSlug": "sequoia-pitch-market-size", "evidence": "Slides 13 and 14 present the market opportunity for BAER-101.", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-a59c-77cf-8e75-229e6c5c9530", "docSlug": "74412512a1adb89488775a4a2b6a1b7b", "documentTitle": "Avenue Therapeutics | IPO Presentation Deck | 30 slides", "authorId": "avenue-therapeutics", "authorName": "Avenue Therapeutics", "documentKindSlug": "regulatory-filing", "documentKindLabel": "Regulatory filing", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 14, "slideType": "key_messages", "function": "establish_context", "notes": "The slide uses a hexagonal layout to present five key product attributes.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a59c-77cf-8e75-229e6c5c9530/14", "deckHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530", "deckAnchorHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530#slide-14", "loopMatches": [ { "to": 14, "from": 11, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "e6485657-8caf-4343-bf92-1e9c148fd1b1", "evidence": "The loop is opened on slide 11, highlighting the limitations of current treatments, and closed on slide 14, presenting BAER-101 as a solution.", "position": 0, "objective": "What are the consequences of not addressing the unmet needs in epilepsy and acute anxiety treatment?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 14, "from": 13, "beatId": "3c1a1939-0c77-485a-99c7-2e27cc46a9e7", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Size", "beatSlug": "sequoia-pitch-market-size", "evidence": "Slides 13 and 14 present the market opportunity for BAER-101.", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-a59c-77cf-8e75-229e6c5c9530", "docSlug": "74412512a1adb89488775a4a2b6a1b7b", "documentTitle": "Avenue Therapeutics | IPO Presentation Deck | 30 slides", "authorId": "avenue-therapeutics", "authorName": "Avenue Therapeutics", "documentKindSlug": "regulatory-filing", "documentKindLabel": "Regulatory filing", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 15, "slideType": "key_takeaways", "function": "summarize", "notes": "The slide notes that BAER-101 was previously known as AZD7325.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a59c-77cf-8e75-229e6c5c9530/15", "deckHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530", "deckAnchorHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530#slide-15", "loopMatches": [], "arcBeatMatches": [ { "to": 16, "from": 15, "beatId": "a2360b6a-b9a0-4abf-8173-d869bbb23b99", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Product", "beatSlug": "sequoia-pitch-product", "evidence": "Slides 15 and 16 present preclinical data supporting the efficacy of BAER-101.", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-a59c-77cf-8e75-229e6c5c9530", "docSlug": "74412512a1adb89488775a4a2b6a1b7b", "documentTitle": "Avenue Therapeutics | IPO Presentation Deck | 30 slides", "authorId": "avenue-therapeutics", "authorName": "Avenue Therapeutics", "documentKindSlug": "regulatory-filing", "documentKindLabel": "Regulatory filing", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 16, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide highlights the therapeutic window of BAER-101 by showing efficacy in the punished model without significant impairment in the un-punished model.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a59c-77cf-8e75-229e6c5c9530/16", "deckHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530", "deckAnchorHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530#slide-16", "loopMatches": [], "arcBeatMatches": [ { "to": 16, "from": 15, "beatId": "a2360b6a-b9a0-4abf-8173-d869bbb23b99", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Product", "beatSlug": "sequoia-pitch-product", "evidence": "Slides 15 and 16 present preclinical data supporting the efficacy of BAER-101.", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-a59c-77cf-8e75-229e6c5c9530", "docSlug": "74412512a1adb89488775a4a2b6a1b7b", "documentTitle": "Avenue Therapeutics | IPO Presentation Deck | 30 slides", "authorId": "avenue-therapeutics", "authorName": "Avenue Therapeutics", "documentKindSlug": "regulatory-filing", "documentKindLabel": "Regulatory filing", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 17, "slideType": "key_takeaways", "function": "summarize", "notes": "Includes a comparison to Cerevel's darigabat and lorazepam.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a59c-77cf-8e75-229e6c5c9530/17", "deckHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530", "deckAnchorHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530#slide-17", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-a59c-77cf-8e75-229e6c5c9530", "docSlug": "74412512a1adb89488775a4a2b6a1b7b", "documentTitle": "Avenue Therapeutics | IPO Presentation Deck | 30 slides", "authorId": "avenue-therapeutics", "authorName": "Avenue Therapeutics", "documentKindSlug": "regulatory-filing", "documentKindLabel": "Regulatory filing", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 18, "slideType": "appendix_data", "function": "analyze_data", "notes": "The chart shows BAER-101 regimens consistently resulting in lower sleepiness rates than Lorazepam.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a59c-77cf-8e75-229e6c5c9530/18", "deckHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530", "deckAnchorHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530#slide-18", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-a59c-77cf-8e75-229e6c5c9530", "docSlug": "74412512a1adb89488775a4a2b6a1b7b", "documentTitle": "Avenue Therapeutics | IPO Presentation Deck | 30 slides", "authorId": "avenue-therapeutics", "authorName": "Avenue Therapeutics", "documentKindSlug": "regulatory-filing", "documentKindLabel": "Regulatory filing", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 19, "slideType": "key_messages", "function": "present_solution", "notes": "Includes a medical warning regarding photosensitivity.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a59c-77cf-8e75-229e6c5c9530/19", "deckHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530", "deckAnchorHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530#slide-19", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-a59c-77cf-8e75-229e6c5c9530", "docSlug": "74412512a1adb89488775a4a2b6a1b7b", "documentTitle": "Avenue Therapeutics | IPO Presentation Deck | 30 slides", "authorId": "avenue-therapeutics", "authorName": "Avenue Therapeutics", "documentKindSlug": "regulatory-filing", "documentKindLabel": "Regulatory filing", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 20, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "The slide uses a comparison table to frame BAER-101's selectivity profile as a competitive advantage.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a59c-77cf-8e75-229e6c5c9530/20", "deckHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530", "deckAnchorHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530#slide-20", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-a59c-77cf-8e75-229e6c5c9530", "docSlug": "74412512a1adb89488775a4a2b6a1b7b", "documentTitle": "Avenue Therapeutics | IPO Presentation Deck | 30 slides", "authorId": "avenue-therapeutics", "authorName": "Avenue Therapeutics", "documentKindSlug": "regulatory-filing", "documentKindLabel": "Regulatory filing", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 21, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a numbered process flow to outline corporate priorities.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a59c-77cf-8e75-229e6c5c9530/21", "deckHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530", "deckAnchorHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530#slide-21", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-a59c-77cf-8e75-229e6c5c9530", "docSlug": "74412512a1adb89488775a4a2b6a1b7b", "documentTitle": "Avenue Therapeutics | IPO Presentation Deck | 30 slides", "authorId": "avenue-therapeutics", "authorName": "Avenue Therapeutics", "documentKindSlug": "regulatory-filing", "documentKindLabel": "Regulatory filing", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 22, "slideType": "key_messages", "function": "establish_context", "notes": "The slide uses a hub-and-spoke style diagram to illustrate the dual mechanism.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a59c-77cf-8e75-229e6c5c9530/22", "deckHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530", "deckAnchorHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530#slide-22", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-a59c-77cf-8e75-229e6c5c9530", "docSlug": "74412512a1adb89488775a4a2b6a1b7b", "documentTitle": "Avenue Therapeutics | IPO Presentation Deck | 30 slides", "authorId": "avenue-therapeutics", "authorName": "Avenue Therapeutics", "documentKindSlug": "regulatory-filing", "documentKindLabel": "Regulatory filing", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 23, "slideType": "key_takeaways", "function": "analyze_data", "notes": "The slide uses bar charts to demonstrate statistical significance (p < 0.001) of the drug over placebo in two different pain models.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a59c-77cf-8e75-229e6c5c9530/23", "deckHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530", "deckAnchorHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530#slide-23", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-a59c-77cf-8e75-229e6c5c9530", "docSlug": "74412512a1adb89488775a4a2b6a1b7b", "documentTitle": "Avenue Therapeutics | IPO Presentation Deck | 30 slides", "authorId": "avenue-therapeutics", "authorName": "Avenue Therapeutics", "documentKindSlug": "regulatory-filing", "documentKindLabel": "Regulatory filing", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 24, "slideType": "timeline", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a59c-77cf-8e75-229e6c5c9530/24", "deckHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530", "deckAnchorHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530#slide-24", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-a59c-77cf-8e75-229e6c5c9530", "docSlug": "74412512a1adb89488775a4a2b6a1b7b", "documentTitle": "Avenue Therapeutics | IPO Presentation Deck | 30 slides", "authorId": "avenue-therapeutics", "authorName": "Avenue Therapeutics", "documentKindSlug": "regulatory-filing", "documentKindLabel": "Regulatory filing", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 25, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a numbered process flow to delineate strategic priorities.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a59c-77cf-8e75-229e6c5c9530/25", "deckHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530", "deckAnchorHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530#slide-25", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-a59c-77cf-8e75-229e6c5c9530", "docSlug": "74412512a1adb89488775a4a2b6a1b7b", "documentTitle": "Avenue Therapeutics | IPO Presentation Deck | 30 slides", "authorId": "avenue-therapeutics", "authorName": "Avenue Therapeutics", "documentKindSlug": "regulatory-filing", "documentKindLabel": "Regulatory filing", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 26, "slideType": "key_messages", "function": "state_demand", "notes": "The slide uses a hexagonal layout to present selection criteria.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a59c-77cf-8e75-229e6c5c9530/26", "deckHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530", "deckAnchorHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530#slide-26", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-a59c-77cf-8e75-229e6c5c9530", "docSlug": "74412512a1adb89488775a4a2b6a1b7b", "documentTitle": "Avenue Therapeutics | IPO Presentation Deck | 30 slides", "authorId": "avenue-therapeutics", "authorName": "Avenue Therapeutics", "documentKindSlug": "regulatory-filing", "documentKindLabel": "Regulatory filing", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 27, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a59c-77cf-8e75-229e6c5c9530/27", "deckHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530", "deckAnchorHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530#slide-27", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-a59c-77cf-8e75-229e6c5c9530", "docSlug": "74412512a1adb89488775a4a2b6a1b7b", "documentTitle": "Avenue Therapeutics | IPO Presentation Deck | 30 slides", "authorId": "avenue-therapeutics", "authorName": "Avenue Therapeutics", "documentKindSlug": "regulatory-filing", "documentKindLabel": "Regulatory filing", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 28, "slideType": "team_bio", "function": "introduce_nominees", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a59c-77cf-8e75-229e6c5c9530/28", "deckHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530", "deckAnchorHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530#slide-28", "loopMatches": [], "arcBeatMatches": [ { "to": 29, "from": 28, "beatId": "082cf897-b0c1-43e2-90f2-e35450751b09", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Team", "beatSlug": "sequoia-pitch-team", "evidence": "Slides 28 and 29 present the management team and board of directors.", "position": 4, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-a59c-77cf-8e75-229e6c5c9530", "docSlug": "74412512a1adb89488775a4a2b6a1b7b", "documentTitle": "Avenue Therapeutics | IPO Presentation Deck | 30 slides", "authorId": "avenue-therapeutics", "authorName": "Avenue Therapeutics", "documentKindSlug": "regulatory-filing", "documentKindLabel": "Regulatory filing", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 29, "slideType": "appendix_disclosure", "function": "establish_context", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a59c-77cf-8e75-229e6c5c9530/29", "deckHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530", "deckAnchorHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530#slide-29", "loopMatches": [], "arcBeatMatches": [ { "to": 29, "from": 28, "beatId": "082cf897-b0c1-43e2-90f2-e35450751b09", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Team", "beatSlug": "sequoia-pitch-team", "evidence": "Slides 28 and 29 present the management team and board of directors.", "position": 4, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-a59c-77cf-8e75-229e6c5c9530", "docSlug": "74412512a1adb89488775a4a2b6a1b7b", "documentTitle": "Avenue Therapeutics | IPO Presentation Deck | 30 slides", "authorId": "avenue-therapeutics", "authorName": "Avenue Therapeutics", "documentKindSlug": "regulatory-filing", "documentKindLabel": "Regulatory filing", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 30, "slideType": "executive_summary", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a59c-77cf-8e75-229e6c5c9530/30", "deckHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530", "deckAnchorHref": "/decks/019de073-a59c-77cf-8e75-229e6c5c9530#slide-30", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-a66b-723c-a13e-82cc67b02974", "docSlug": "d185d124064a736268087b4a4ca48bef", "documentTitle": "Bank of America | Results Presentation Deck | 36 slides", "authorId": "bank-of-america", "authorName": "Bank of America", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.2938006, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/4YZP-SzrKKKfpYN7HEuJurBHoC6SVlEckRKVxkkX-io/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kMTg1ZDEyNDA2NGE3MzYyNjgwODdiNGE0Y2E0OGJlZi9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a66b-723c-a13e-82cc67b02974/1", "deckHref": "/decks/019de073-a66b-723c-a13e-82cc67b02974", "deckAnchorHref": "/decks/019de073-a66b-723c-a13e-82cc67b02974#slide-1", "loopMatches": [], "arcBeatMatches": [ { "to": 2, "from": 1, "beatId": "736cf5c9-4863-479a-a107-3c98586bd247", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Attention", "beatSlug": "aida-attention", "evidence": "The presentation begins with a cover slide and an overview of 3Q22 financial results, grabbing the audience's attention", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": "https://imgproxy.kitesheet.com/fmOmW9IAloUyrBSavSG2xu4pZ-jftWxxyOQXQRr9Jg4/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kMTg1ZDEyNDA2NGE3MzYyNjgwODdiNGE0Y2E0OGJlZi9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/nGkrpmTfnvfrGOUeXJYr57B512i7VUBqjgjJ2UUkaWc/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kMTg1ZDEyNDA2NGE3MzYyNjgwODdiNGE0Y2E0OGJlZi9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/z7dEocWqnjgmrYQFH9j_AQeAK_c8jGYlql34G3cze3s/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kMTg1ZDEyNDA2NGE3MzYyNjgwODdiNGE0Y2E0OGJlZi9wMDAxLnBuZw" }, { "docId": "019de073-a66b-723c-a13e-82cc67b02974", "docSlug": "d185d124064a736268087b4a4ca48bef", "documentTitle": "Bank of America | Results Presentation Deck | 36 slides", "authorId": "bank-of-america", "authorName": "Bank of America", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.2938006, "pageNumber": 2, "slideType": "kpi_overview", "function": "analyze_data", "notes": "Includes footnotes regarding reserve build, non-GAAP measures, and rounding.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a66b-723c-a13e-82cc67b02974/2", "deckHref": "/decks/019de073-a66b-723c-a13e-82cc67b02974", "deckAnchorHref": "/decks/019de073-a66b-723c-a13e-82cc67b02974#slide-2", "loopMatches": [ { "to": 11, "from": 2, "name": "Logic Chain", "slug": "01-logic-chain", "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis", "matchId": "0b28f624-b349-4558-a1e1-ad61c5726ab0", "evidence": "The presentation provides a clear and logical explanation of the company's financial results", "position": 0, "objective": "To demonstrate the logic behind Bank of America's financial performance", "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)", "confidence": 0.7, "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion" } ], "arcBeatMatches": [ { "to": 2, "from": 1, "beatId": "736cf5c9-4863-479a-a107-3c98586bd247", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Attention", "beatSlug": "aida-attention", "evidence": "The presentation begins with a cover slide and an overview of 3Q22 financial results, grabbing the audience's attention", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" }, { "to": 30, "from": 2, "beatId": "7624b78d-b6d7-4a43-a707-d32b7a80a852", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "KPI Overview", "beatSlug": null, "evidence": "The presentation provides a detailed overview of key performance indicators, including financial metrics and trends", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-a66b-723c-a13e-82cc67b02974", "docSlug": "d185d124064a736268087b4a4ca48bef", "documentTitle": "Bank of America | Results Presentation Deck | 36 slides", "authorId": "bank-of-america", "authorName": "Bank of America", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.2938006, "pageNumber": 3, "slideType": "kpi_overview", "function": "summarize", "notes": "The slide uses a 2x2 grid layout to present segment-specific performance metrics.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a66b-723c-a13e-82cc67b02974/3", "deckHref": "/decks/019de073-a66b-723c-a13e-82cc67b02974", "deckAnchorHref": "/decks/019de073-a66b-723c-a13e-82cc67b02974#slide-3", "loopMatches": [ { "to": 11, "from": 2, "name": "Logic Chain", "slug": "01-logic-chain", "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis", "matchId": "0b28f624-b349-4558-a1e1-ad61c5726ab0", "evidence": "The presentation provides a clear and logical explanation of the company's financial results", "position": 0, "objective": "To demonstrate the logic behind Bank of America's financial performance", "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)", "confidence": 0.7, "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion" } ], "arcBeatMatches": [ { "to": 30, "from": 2, "beatId": "7624b78d-b6d7-4a43-a707-d32b7a80a852", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "KPI Overview", "beatSlug": null, "evidence": "The presentation provides a detailed overview of key performance indicators, including financial metrics and trends", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-a66b-723c-a13e-82cc67b02974", "docSlug": "d185d124064a736268087b4a4ca48bef", "documentTitle": "Bank of America | Results Presentation Deck | 36 slides", "authorId": "bank-of-america", "authorName": "Bank of America", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.2938006, "pageNumber": 4, "slideType": "kpi_overview", "function": "analyze_data", "notes": "Includes four distinct charts tracking payment volume, transaction growth, and deposit balances.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a66b-723c-a13e-82cc67b02974/4", "deckHref": "/decks/019de073-a66b-723c-a13e-82cc67b02974", "deckAnchorHref": "/decks/019de073-a66b-723c-a13e-82cc67b02974#slide-4", "loopMatches": [ { "to": 11, "from": 2, "name": "Logic Chain", "slug": "01-logic-chain", "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis", "matchId": "0b28f624-b349-4558-a1e1-ad61c5726ab0", "evidence": "The presentation provides a clear and logical explanation of the company's financial results", "position": 0, "objective": "To demonstrate the logic behind Bank of America's financial performance", "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)", "confidence": 0.7, "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion" } ], "arcBeatMatches": [ { "to": 30, "from": 2, "beatId": "7624b78d-b6d7-4a43-a707-d32b7a80a852", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "KPI Overview", "beatSlug": null, "evidence": "The presentation provides a detailed overview of key performance indicators, including financial metrics and trends", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-a66b-723c-a13e-82cc67b02974", "docSlug": "d185d124064a736268087b4a4ca48bef", "documentTitle": "Bank of America | Results Presentation Deck | 36 slides", "authorId": "bank-of-america", "authorName": "Bank of America", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.2938006, "pageNumber": 5, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses a combination of area charts to visualize delinquency volumes over time, with a callout box summarizing key performance drivers and metrics.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-a66b-723c-a13e-82cc67b02974/5", "deckHref": "/decks/019de073-a66b-723c-a13e-82cc67b02974", "deckAnchorHref": "/decks/019de073-a66b-723c-a13e-82cc67b02974#slide-5", "loopMatches": [ { "to": 11, "from": 2, "name": "Logic Chain", "slug": "01-logic-chain", "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis", "matchId": "0b28f624-b349-4558-a1e1-ad61c5726ab0", "evidence": "The presentation provides a clear and logical explanation of the company's financial results", "position": 0, "objective": "To demonstrate the logic behind Bank of America's financial performance", "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)", "confidence": 0.7, "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion" } ], "arcBeatMatches": [ { "to": 30, "from": 2, "beatId": "7624b78d-b6d7-4a43-a707-d32b7a80a852", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "KPI Overview", "beatSlug": null, "evidence": "The presentation provides a detailed overview of key performance indicators, including financial metrics and trends", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }